tailieunhanh - Báo cáo khoa học: "High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Radiation Oncology cung cấp cho các bạn kiến thức về ngành y đề tài: "High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina. | Radiation Oncology o BioMed Central High-dose rate brachytherapy HDRB for primary or recurrent cancer in the vagina Sushil Beriwal 1 Dwight E Heron1 Robert Mogus1 Robert P Edwards2 Joseph L Kelley2 and Paniti Sukumvanich2 Address Department of Radiation Oncology University of Pittsburgh Cancer Institute Pittsburgh PA USA and 2Division of Gynecologic Oncology Department of Obstetrics Gynecology and Reproductive Sciences Magee-Womens Hospital University of Pittsburgh Medical Center Pittsburgh PA USA Email Sushil Beriwal - beriwals@ Dwight E Heron - herond2@ Robert Mogus - mogusr@ Robert P Edwards - redwards@ Joseph L Kelley - jkelley@ Paniti Sukumvanich - psukumvanich@ Corresponding author Published 13 February 2008 Received 29 August 2007 Radiation Oncology 2008 3 7 doi 1748-7I7X-3-7 Accepted 13 February 2008 This article is available from http content 3 1 7 2008 Beriwal et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Purpose The purpose of this study was to evaluate the efficacy of HDR brachytherapy for primary or recurrent vaginal cancer. Methods Between the years 2000 to 2006 18 patients with primary or recurrent vaginal cancer were treated with brachytherapy HDRB . Six patients had primary vaginal cancer stage II to IVA while 12 were treated for isolated vaginal recurrence primary cervix 4 vulva 1 and endometrium 7 . Five patients had previous pelvic radiation therapy. All except one patient received external beam radiation therapy to a median dose of 45 Gy range Gy . The HDRB was intracavitary using a vaginal cylinder in 5 patients and interstitial using a modified Syed-Nesblett template in 13 patients. The dose of .

TÀI LIỆU LIÊN QUAN
crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.